Skip to main content
logo
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China flag China · Delayed Price · Currency is CNY
30.60
-0.04 (-0.13%)
Jul 31, 2026, 3:00 PM CST

SHA:603392 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,9421,8192,2455,51111,1855,750
Revenue Growth
2.54%-18.99%-59.25%-50.73%94.51%144.25%
Gross Profit
790.77691.81,3794,4279,9874,900
Operating Income
-700.18-730.56-312.221,3645,2652,238
Net Income
-388.47-398.27106.241,2484,7362,021
Earnings Per Share
-0.30-0.310.080.993.791.64
EPS Growth
---91.92%-73.88%130.69%190.01%

Revenue by Segment
Chart
Fiscal YearFY 2025
Period EndingDec '25
Intersegment Offset
-317.38
Diagnostic Division
1,626
Vaccine Division
457.05
Total
1,766

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4,3095,0505,3785,8747,2011,656
Total Debt
355.03354.39382.91309.35277.86287.06
Net Cash (Debt)
3,9544,6954,9955,5656,9231,369
Net Cash Growth
-7.12%-6.00%-10.23%-19.63%405.71%86.03%
Net Cash Per Share
3.013.653.764.425.541.11

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-56.3289.75355.081,5384,1331,682
Capital Expenditures
-750.09-805.16-887.35-1,160-929.91-1,048
Free Cash Flow
-806.4-715.41-532.27378.153,203634.16
Free Cash Flow Growth
----88.19%405.03%715.43%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
40.73%38.03%61.42%80.34%89.29%85.21%
Operating Margin
-36.06%-40.16%-13.91%24.75%47.07%38.91%
Pretax Margin
-24.87%-26.44%3.01%25.28%49.91%40.42%
Profit Margin
-20.01%-21.89%4.73%22.64%42.34%35.15%
FCF Margin
-41.53%-39.33%-23.71%6.86%28.63%11.03%

Dividends
Chart
Fiscal YearFY 2023FY 2022FY 2021
Period EndingDec '23 Dec '22 Dec '21
Dividend Per Share
0.3200.7140.099
Dividend Per Share Growth
-55.20%624.44%12.04%
Dividend Yield
0.43%0.80%0.09%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--839.0976.3724.2466.52
Forward PE
-144.0848.6417.2920.4776.21
P/FCF Ratio
---251.9635.85212.03
PS Ratio
19.9331.2439.7017.2910.2623.38